Bora Pharmaceuticals Co. Ltd. has announced plans to add further sterile fill/finish capacity at its facility in Baltimore, ...

In today’s high-stakes pharma environment, where supply chain risks, rising tariffs, and time-to-market pressures dominate, ...

Bionique Testing Laboratories and Cellipont Bioservices have partnered to advance the adoption and validation of rapid ...

Hillstar Bio, a leading biotechnology company focused on developing immunology therapies for autoimmune diseases, appointed ...

Collaboration combines Nuclera’s eProtein Discovery System with Cytiva’s Biacore SPR system.

TQ Therapeutics GmbH (TQx) has acquired Juno Therapeutics GmbH, a cell therapy company, through a share purchase agreement.

Mettler-Toledo Product Inspection has introduced the Test Before You Invest program, which is designed to help food, pharmaceutical, and packaging manufacturers make informed product inspection ...

GRIN Therapeutics Inc. and Angelini Pharma have partnered for the development and commercial rights outside of North America ...

Eli Lilly and Company has agreed to acquire SiteOne Therapeutics Inc., a private biotech company developing small molecule ...

The development of oral dosage forms for clinical trials presents a unique set of challenges, particularly in early phases of ...

Hansa Biopharma AB, which appointed a new CEO and COO earlier this year, has announced plans to restructure its organization.

Toxicological testing is a high-stakes process that ensures the safety of large- and small-molecule therapies before they reach patients.